{"url_path":"/sec/bdtb/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information.**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/2041531/0001829126-26-005192-index.html","accession_number":"0001829126-26-005192","cik":"0002041531","ticker":"BDTB","issuer_name":"Bodhi Tree Biotechnology Inc","edgar_url":"https://www.sec.gov/Archives/edgar/data/2041531/0001829126-26-005192-index.html","primary_entity_key":"0002041531","primary_entity_name":"Bodhi Tree Biotechnology Inc"},"word_count":76,"has_tables":true,"body_markdown":"**Item 5. Other Information.**\n\n** **\n\nDuring the quarter ended March 31, 2026, the Company’s application to have its common stock quoted on the OTCQB Venture Market was approved. In connection with the OTCQB listing requirements, the Company removed restrictive legends from certain shares of its common stock in order to increase its public float. There were no other material developments during the period covered by this report that are required to be disclosed under this Item.\n\n****\n\n \n\n18"}